25 June 2018
(“AfriAg Global” or the “Company”)
Proposed Expansion of Investment Policy to Include the Medicinal Cannabis Sector
The Directors believe that there are numerous investment opportunities within both private and public businesses that operate in the legalised medicinal cannabis sector in jurisdictions that are internationally recognised as having well-developed and reputable laws and regulations that govern this sector.
On adoption of the proposed new investing policy, the Company intends to appoint a medicinal cannabis advisory board comprising individuals with the relevant experience and knowledge in the sector to carry out appropriate due diligence on assets and businesses in the medicinal cannabis sector and to provide on-going monitoring of investments once made. Prior to any investments being made the Company intends to conduct legal, accounting and technical due diligence using appropriately qualified personnel for such activities and shall in particular seek and obtain appropriate legal advice to ensure that any investments or partnerships made will comply in all respects with the laws in those jurisdictions in which investments are made as well as the laws of the
The Company’s Chairman has experience in this sector, serving as Co-Chairman of Canadian listed LGC Capital Ltd, which is currently engaged with investments and potential investments in
The directors of the Company accept responsibility for the contents of this announcement.
Doriemus Plc: +44 (0)20 7440 0640
David Lenigas(Executive Chairman) Anthony Samaha(Finance Director) Hamish Harris Donald Strang Peterhouse Capital Limited+44 (0)20 7469 0930 Guy Miller Fungai Ndoro